Details for: APO-ONDANSETRON
Company: APOTEX INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02288184 | APO-ONDANSETRON | ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE) | 4 MG | TABLET | ORAL |
| 02291967 | APO-ONDANSETRON | ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE) | 4 MG / 5 ML | SOLUTION | ORAL |
| 02288192 | APO-ONDANSETRON | ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE) | 8 MG | TABLET | ORAL |
Summary Reports
Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm to the Fetus
Summary Safety Review - Serotonin blocking drugs (serotonin antagonists) ALOXI® (palonosetron), ANZEMET® (dolasetron), KYTRIL® (granisetron) and generics, and ZOFRAN® (ondansetron) and generics - Serotonin Syndrome
Summary Safety Review - Serotonin blocking drugs (serotonin antagonists) ALOXI® (palonosetron), ANZEMET® (dolasetron), KYTRIL® (granisetron) and generics, and ZOFRAN® (ondansetron) and generics - Serotonin Syndrome
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.